Beijing Science Sun Pharmaceutical Co Ltd Financial Flexibility Index
Beijing Science Sun Pharmaceutical Co Ltd financial flexibility index. Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥44.20 Million (operating CF CN¥28.68 Million minus capex CN¥15.52 Million) represents 0% of total liabilities (CN¥171.26 Million). See Beijing Science Sun Pharmaceutical Co Lt (300485) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
Financial flexibility index of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Beijing Science Sun Pharmaceutical Co Ltd across 15 annual periods. Check Beijing Science Sun Pharmaceutical Co Lt earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Beijing Science Sun Pharmaceutical Co Ltd Financial Flexibility Index by Year (2011–2025)
Beijing Science Sun Pharmaceutical Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Beijing Science Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Beijing Science Sun Pharmaceutical Co Lt (300485) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.72x | CN¥127.36 Million | CN¥27.08 Million | CN¥175.95 Million | ▼ -49.2% |
| 2024 | 1.42x | CN¥237.10 Million | CN¥135.97 Million | CN¥166.48 Million | ▲ +197.1% |
| 2023 | 0.48x | CN¥74.12 Million | CN¥21.21 Million | CN¥154.61 Million | ▼ -51.0% |
| 2022 | 0.98x | CN¥153.72 Million | CN¥110.43 Million | CN¥157.10 Million | ▼ -49.4% |
| 2021 | 1.93x | CN¥229.21 Million | CN¥183.30 Million | CN¥118.54 Million | ▼ -28.5% |
| 2020 | 2.70x | CN¥381.57 Million | CN¥263.73 Million | CN¥141.13 Million | ▼ -10.2% |
| 2019 | 3.01x | CN¥283.94 Million | CN¥172.52 Million | CN¥94.26 Million | ▲ +79.3% |
| 2018 | 1.68x | CN¥344.52 Million | CN¥146.52 Million | CN¥205.07 Million | ▼ -9.8% |
| 2017 | 1.86x | CN¥249.47 Million | CN¥108.21 Million | CN¥133.91 Million | ▼ -38.6% |
| 2016 | 3.03x | CN¥359.89 Million | CN¥212.89 Million | CN¥118.63 Million | ▼ -6.4% |
| 2015 | 3.24x | CN¥201.01 Million | CN¥169.36 Million | CN¥62.00 Million | ▲ +4.1% |
| 2014 | 3.11x | CN¥223.27 Million | CN¥214.23 Million | CN¥71.71 Million | ▼ -31.9% |
| 2013 | 4.57x | CN¥216.25 Million | CN¥196.82 Million | CN¥47.33 Million | ▼ -30.9% |
| 2012 | 6.62x | CN¥232.69 Million | CN¥151.93 Million | CN¥35.18 Million | ▲ +105.3% |
| 2011 | 3.22x | CN¥104.36 Million | CN¥77.06 Million | CN¥32.39 Million | — |